Streetbeat News

Regulatory

PRTC

PureTech's LYT-200 has received FDA Fast Track Designation for the treatment of head and neck cancers, indicating a potential acceleration in its development and review process.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:18 am

SEDG

SolarEdge announced its entire product portfolio complies with the UK's upcoming Product Security and Telecommunications Infrastructure (PSTI) regulation, effective April 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:15 am

ONCY

Oncolytics Biotech has submitted a Type C meeting request to the FDA to discuss its planned registration-enabling trial for pelareorep in HR+/HER2- metastatic breast cancer. The company anticipates meeting with the FDA in Q2 2024, aiming for a transformative year with the expected overall survival data from the BRACELET-1 study.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:05 am

AZN

The FDA has approved AstraZeneca's Fasenra (Benralizumab) for add-on maintenance treatment for severe asthma in patients aged 6 to 11 with an eosinophilic phenotype. This expands its previous approval for patients aged 12 and older.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:02 am

ACM

AECOM announced its engagement with clients across the US to address the new final regulatory rules announced by the US Environmental Protection Agency (EPA). This proactive approach by AECOM demonstrates its commitment to assisting clients in navigating the complexities of environmental compliance and regulation.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 10:56 am

DIA

GLD

QQQ

SPY

USO

US stock markets fell after unexpectedly high inflation data, with the S&P 500, Dow Jones, and Nasdaq all closing lower. Inflation in the US rose to 3.5% in March, impacting global markets with mixed results in Asia and Europe. Commodities saw gold trading above $2,350, while crude oil prices dropped.

Portfolio Pulse from Akanksha Bakshi

April 11, 2024 | 10:47 am

ISPR

Ispire Technology and Chemular Inc have entered into a joint venture to develop an industry-standard age-verification solution and to seek FDA marketing orders for the e-cigarette market in the US.

Portfolio Pulse from Charles Gross

April 11, 2024 | 10:23 am

BCLI

BrainStorm Cell Therapeutics Inc. (BCLI) has regained compliance with NASDAQ's minimum market value requirement, ensuring its continued listing on the stock market. This follows a notification from NASDAQ confirming the company meets the necessary market value criteria.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 10:02 am

AAPL

MSFT

Apple Inc. has issued an alert to users in 92 countries about a sophisticated 'mercenary spyware attack' targeting iPhones. This is part of ongoing efforts since 2021 to warn users about state-sponsored cyber threats. The alert coincides with a global increase in cyber-espionage, highlighted by recent security breaches at Microsoft and warnings of AI-generated disinformation in upcoming elections. Google's report also identified China as a major source of government-backed cyber threats.

Portfolio Pulse from Benzinga Neuro

April 11, 2024 | 9:14 am

YSG

Yatsen Holding Limited (YSG), a leading China-based beauty group, announced it has regained compliance with the NYSE's minimum share price continued listing criterion, according to a letter from the NYSE dated April 10, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 9:07 am